$RKLB

Rocket Lab USA GAAP EPS of -$0.08 in-line, revenue of $234.06M beats by $3.12M (RKLB:NASDAQ)

Rocket Lab USA reported Q2 GAAP EPS of -$0.08, in line with expectations, and revenue of $234.06M, up 62% year over year, which it said beat estimates by $3.12M. For Q3 2026, the company forecast revenue of $250M to $265M versus $235.90M consensus.

Original reporting
Published Aug 10, 2026, 11:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 11:25 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$RKLB
Bullish
medium confidence
Mentioned
$RKLB
Relevance
8/10
alphai data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$RKLBBullishMed
01

Why it matters

Traders can use the Q3 revenue range ($250M-$265M) relative to $235.90M consensus to update near-term growth expectations; the in-line GAAP EPS suggests the main surprise is revenue, not earnings power.

02

Market read

Company-specific earnings and guidance datapoints are likely to drive immediate repricing of revenue growth expectations.

03

What to watch

The excerpt is incomplete on GAAP details and does not include cash flow, backlog, margins, or segment performance, which could temper the reaction despite the revenue beat and guidance.

Relevance 8/10Novelty 6/10Timing: after-hours/late-day earnings release (published 2026-08-10 23:00 UTC)

Background

The piece summarizes Rocket Lab’s Q2 results and provides Q3 2026 revenue guidance versus consensus.

Company-level read

Ticker impact

$RKLBBullishMedium confidence
Context

Rocket Lab reported Q2 GAAP EPS of -$0.08 in-line and revenue of $234.06M, beating by $3.12M, plus Q3 revenue guidance.

Expected impact

Likely positive bias for the stock into the next session as traders reprice growth expectations from the raised guidance range.

Evidence & confidence

The article discloses a concrete earnings/guidance datapoint (revenue beat and Q3 revenue range above consensus) that typically drives revisions and short-term positioning.

Market effects

Reinforces demand and execution expectations for space launch and satellite services, potentially supporting sentiment across small/mid-cap space names.

Primarily US-listed small-cap growth sentiment; limited direct regional spillover from the provided text.

Modest global relevance, as the disclosed facts are company-specific financial results and guidance.

Counterpoint

In-line GAAP EPS (still negative) may limit upside if investors focus on profitability trajectory rather than revenue growth.

Key entities

  • Rocket Lab USA

    Reported Q2 GAAP EPS of -$0.08 in-line and revenue of $234.06M, and guided Q3 2026 revenue to $250M-$265M.

Related articles

$RKLBMedAI 8/10

Rocket Lab (RKLB) Q2 2026: Record Revenue, Acquisitions Dent EPS

Rocket Lab reported Q2 2026 revenue of $234.07M, above the $230.94M consensus, up 62% year over year. Product revenue rose to $181.35M. GAAP EPS was -$0.08 versus -$0.0767, with the miss linked to $8.6M acquisition-related transaction costs. Backlog grew to $2.36B and Q3 revenue guidance was $250M-$265M.

$RKLBMedAI 8/10

Rocket Lab Just Delivered Record Results. So Why Is the Stock Sinking?

Rocket Lab (RKLB) reported Q2 record revenue of $234 million, up 62% year over year, and a net loss of $49 million, or $0.08 per share. Revenue beat consensus ($231.6 million) but loss was wider than expected ($0.03). Backlog rose 137% to $2.36 billion, with $1B+ new contracts and $397 million U.S. Space Force Flatellites deal. Q3 revenue guidance is $250-$265 million.

$RKLBHighAI 8/10

Live: Will Rocket Lab Soar Back to All-Time Highs After Q2 Earnings Tonight?

Rocket Lab (NASDAQ:RKLB) is set to report Q2 FY2026 earnings on Aug. 10. Management guided Q2 revenue to $225M-$240M, about 60% YoY growth, supported by a $2.2B backlog and recent defense contract wins including a $266M Space Force suborbital contract and $397M Flatellites award. The article highlights Neutron timing and margin deceleration as key investor focus.

$RKLBMed

Window for 2026 launch debut of Rocket Lab’s Neutron rocket ‘is narrowing’ as development continues – Spaceflight Now

Rocket Lab said in an SEC filing that Neutron’s end-of-year launch window is narrowing, with Stage 1 tank production aligned to a Q4 2026 delivery to the launch pad. Exact timing depends on first-stage qualification and other tests. The company also cited a $397 million US Space Force SB-AMTI contract and a dedicated Kepler mission no earlier than 2028.

$RKLBMed

Rocket Lab Q2 Loss Narrows

Rocket Lab Corp (RKLB) reported Q2 results with revenue up 62% year over year to $234.1 million. Net loss narrowed to $49.3 million, or $0.08 per share, from $66.4 million, or $0.13 per share. For Q3, the company forecast revenue of $250 million to $265 million and gross margin of 29% to 31%.